menu search

Biostem technologies closes oversubscribed $2m private placement

POMPANO BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the ...

November 3, 2023, 12:30 pm

Centers for medicare & medicaid services establishes new category i cpt® add-on code for coronary ivl

New Add-On Code Goes Into Effect January 1, 2024 SANTA CLARA, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pio...

November 3, 2023, 12:00 pm

Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...

November 2, 2023, 6:30 am

Correction – gynesonics announces $67m financing to expand commercialization of sonata® procedure

Existing and New Investors Participated in Support of Rapid commercialization REDWOOD CITY, Calif., Nov...

November 2, 2023, 12:08 am

Olema oncology to participate in upcoming investor conferences in november

SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biop...

November 1, 2023, 8:27 pm

Avicanna to hold third quarter 2023 earnings conference call

TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical ...

November 1, 2023, 5:55 pm

Olema oncology to participate in upcoming investor conferences in november

SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage bioph...

November 1, 2023, 4:27 pm

Why is aldeyra therapeutics (aldx) stock up 40% today?

Aldeyra Therapeutics (NASDAQ: ALDX ) stock is on the rise Wednesday after entering into an exclusive option agreement with AbbVie (NYSE: ABBV ). This ...

November 1, 2023, 10:34 am

Quantumscape stock: bull vs. bear

After soaring on their debut, shares of the EV battery maker have slumped. The battery's progress toward comme...

November 1, 2023, 8:45 am

Ormat technologies: egs could provide unexpected upside

EGS is still an unproven technology, but there has been recent progress towards commercialization. Orma...

October 31, 2023, 3:55 pm

Ideal power to host third quarter 2023 results conference call on november 14, 2023 at 10:00 am eastern time

AUSTIN, TX / ACCESSWIRE / October 31, 2023 / Ideal Power Inc. ("Ideal Power," the "Company," "we," "us" or "our") (NASDAQ:IPWR), pioneering the develo...

October 31, 2023, 9:20 am

Pharmadrug to acquire securedose synthetics in all-stock deal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) announced that it will acquire all of the issued and outstanding shares of Securedose Synthetics Inc, a privat...

October 27, 2023, 9:07 am

Shockwave medical announces details for conference call discussing third quarter 2023 results and participation in upcoming investor conference

SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and ...

October 26, 2023, 4:30 pm

Reneo pharmaceuticals announces poster presentation at upcoming scientific meetings

IRVINE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

October 25, 2023, 11:50 am

Google: shares likely to pop on strong earnings

Google's Q3 earnings are expected to show growth in revenue and earnings, with estimates of 10% and 36% YoY growth respectively. Factors driving this ...

October 22, 2023, 9:34 am

Xencor: a mid-stage clinical company with falling losses

Xencor, Inc. is a biotech company focused on the development and commercialization of anticancer medica...

October 20, 2023, 11:02 pm

Ultragenyx announces pricing of public offering of common stock and pre-funded warrants

NOVATO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developme...

October 19, 2023, 1:16 am

3 space stocks to invest in for sky-high returns

As we venture through the burgeoning universe of space stocks, the investment landscape finds itself in a mix of anticipation and caution. The rapid d...

October 17, 2023, 1:58 pm

Hashicorp: a solid business model and a huge opportunity

HashiCorp was created to provide automation tools for organizations adopting multiple clouds. HashiCorp offers a unique product portfolio that covers ...

October 17, 2023, 12:23 pm

89bio to participate in the h.c. wainwright 7ᵗʰ annual nash investor conference

SAN FRANCISCO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

October 17, 2023, 8:00 am


Search within

Pages Search Results: